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Transmembrane poreThe effects of the polyene pore-forming agent nystatin were investigated on individual giant unilamellar phospho-
lipid vesicles (GUVs), made of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), in different methanol–
water solutions using phase-contrast opticalmicroscopy. Three characteristic effectswere detected in three different
nystatin concentration ranges: vesicle shape changes (between 150 and 250 μM); transient, nonspeciﬁc, tension
pores (between 250 and 400 μM); and vesicle ruptures (above 400 μM). Both the appearance of the transient ten-
sion pores and the vesicle ruptureswere explained as being a consequence of the formationof size-selective nystatin
channels, whose membrane area density increases with the increasing nystatin concentrations. Our results also
show that nystatin is able to formpores in the absence of sterols. In addition, study of the cross-interactions between
nystatin andmethanol revealedmutually antagonizing effects on thevesicle behavior formethanol volume fractions
higher than 10%.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
Polyene antibiotics are a class of biologically active bacterial me-
tabolites isolated from Streptomyces, an aerobic actinomycete genus
obtained from soil. While more than one hundred polyene antibiotics
have been described, amphotericin B (AmB) and nystatin are the two
agents most commonly used to treat fungal and protozoal infections
in humans [1]. In fact, AmB has been the most common antifungal
agent used to treat invasive systemic fungal infections in critically ill
patients over the past 50 years. This can be ascribed to its wide spec-
trum of activity towards pathogenic fungi in comparison to many
other antifungal compounds, e.g., azoles [2,3]. However, several side
effects, especially nephrotoxicity and hepatotoxicity, have limited its
use. In order to minimize these problems, various liposomal formula-
tions were developed [4]. In contrast to AmB, the use of nystatin is
currently limited almost exclusively to the topical treatment of super-
ﬁcial Candida infections, since it is not effective when given orally and
is severely toxic as an intravenous application [4]. Nevertheless, nys-
tatin has recently been successfully incorporated into liposomal phar-
maceutical formulations, which reduced its toxicity dramatically
without losing its therapeutic properties [5,6]. It has been shown
that the antifungal activity of nystatin is broader in comparison to
AmB and could, therefore, be more effective when given by the intra-
venous route [7]. As a pore-forming agent, nystatin could also beulty of Medicine, University of
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l rights reserved.capable of translocating different cargo molecules into the cells,
which makes it a potential speciﬁc drug-delivery agent [8]. Therefore,
in order to develop even more acceptable nystatin formulations, it is
essential to know in greater detail its mode of action at the membrane
level.
The biological target for polyene action is the plasmamembrane of
the antibiotic-sensitive organisms, where polyenes are believed to
exert their function through the formation of barrel-like,
membrane-spanning channels [1,9,10]. Several electrophysiological
studies have shown that bilayer-spanning, potassium-selective chan-
nels are formed after the one-sided addition of nystatin or AmB to dif-
ferent lipid membranes [11]. These pores have size-selective
properties, being permeable only to solutes not larger than glucose,
in the case of nystatin, or sucrose, in the case of AmB [12,13]. The dis-
turbance of the cellular electrochemical gradients, caused by the in-
crease of the plasma-membrane permeability to ions and small
molecules, ultimately leads to cell lysis and death [1]. Bacteria have
membranes that are completely devoid of sterols and are insensitive
to polyene antibiotics. In relation to this, it was proposed that their
mode of action must be in some way connected to the sterols in the
membrane [14–18]. Consequently, many different molecular models
describing the role of sterols have been presented, including the for-
mation of speciﬁc antibiotic-sterol complexes [10,19–21] and/or an
increased membrane partition of polyene antibiotics due to a change
in the overall membrane lipid organization inﬂuenced by sterols
[22,23]. The exact molecular mechanisms have, however, not been re-
solved yet. The problems are even more complex if, in addition, the
inﬂuence of the membrane phospholipid composition on the pore-
forming effect of polyenes is considered [24,25]. Furthermore, it has
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are also able to form pores in membranes that do not contain any ste-
rols [26–29].
Extensive research efforts have beenmade in the area of the polyene
molecular activities exerted on lipid bilayers of small unilamellar vesi-
cles (SUVs) and large unilamellar vesicles (LUVs) [10,26,30,31]. The
bulk properties of the membrane-polyene interactions were primarily
studied using different ﬂuorescent techniques [10,30,31]. In contrast
to this, there is a lack of research on single vesicles with dimensions
more comparable to the size of an average human cell, i.e., research
on giant unilamellar vesicles (GUVs).
In this article we report on studies focusing on individual GUVs,
which reveal the characteristic behavior patterns of lipid vesicles when
exposed to nystatin at different concentrations. Our vesicles were
made solely out of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC)whichwas chosen due to its abundance in biologicalmembranes
and its chemical characteristics. Its gel-ﬂuid phase transition tempera-
ture at about −2.6 °C [32] makes it appropriate for the studies in the
ﬂuid phase,which is characteristic for the lipids in biologicalmembranes.
In addition, POPC is one of the most commonly used phospholipids
which enables an easier comparison to other studies. The GUVs, selected
and manipulated by the micropipette technique under phase-contrast
microscopy, demonstrated complex concentration-dependent interac-
tions with the nystatin. In addition, as methanol is commonly used as
a cosolvent for nystatin in experimental procedures, we dealt in some
detail with the interactions of methanol and nystatin at the lipid-
membrane level.
2. Materials and methods
2.1. Preparation of vesicles (GUVs) and nystatin stock solutions
The GUVs were prepared from POPC (Avanti Polar Lipids, USA)
according to the modiﬁed method of Angelova et al. [33] in a 0.2 M
sucrose solution with a pH of 7.5. The lipid (POPC) was dissolved
in a chloroform–methanol mixture (1:1, vol/vol), spread over wire
platinum electrodes and then vacuum dried. The electrodes were
placed in an electroformation chamber, ﬁlled with 2 ml of sucrose
solution. AnACﬁeld of 1 V/mmand10 Hzwas applied for 2 hours, after-
wards reduced to 0.5 V/mm and 5 Hz for 15 min, and then 0.25 V/mm
and 2 Hz for the next 15 min. Finally, an AC ﬁeld of 0.1 V/mm and 1 Hz
was applied for 30 min. The vesicles formed with the entrapped sucrose
solution were transferred to an isomolar glucose solution and were kept
at 4 °C. The samples were used within 3 days of preparation.
Stock solutions of 1 mMand 10mMnystatinwere prepared using ly-
ophilized nystatin (Fluka, Sigma, USA) and stored at −20 °C in a dark
place. Pure methanol was used as a solvent due to the poor solubility of
nystatin inwater. Before the experiment, the stock solutionswere stirred
using a magnetic stirrer and diluted with 0.2 M glucose solution in order
to obtain nystatin solutions with the desired concentrations.
2.2. Observation and manipulation of vesicles
The effects of nystatin on the giant phospholipid vesicles were ob-
served using phase-contrast microscopy. An inverted microscope
(IMT-2, Olympus, Japan; objective LWD CDPlan40X, NA=0.55) was
used. The images were continuously acquired with a chilled black-
and-white CCD camera (C5985, Hamamatsu, Japan) and recorded on
a video recorder (VCR, Sony, SVO-9500 MDP, Japan). The images se-
lected for the quantitative determination were also digitized using an
8-bit frame grabber (DT 2851, Data Translation Inc., USA) and stored
in a personal computer. All the images were processed and analyzed
using in-house-produced software.
A two-compartment cell was used to select and transfer the indi-
vidual vesicles. One compartment was ﬁlled with the prepared vesicle
solution, while the other, measuring compartment, was ﬁlled withisomolar glucose solution and nystatin in the desired concentrations.
The sugar concentrations were equal to 0.2 M in both compartments.
The volume of the measuring compartment was around 80 μl. Indi-
vidual unilamellar, nearly spherical vesicles with a diameter of ap-
proximately 40 μm were chosen and transferred in groups of 1 to 5
vesicles into the measuring compartment using a micropipette ma-
nipulation system. Since the volume of the transferred solution was
much smaller compared to the volume of the measuring compart-
ment, the concentration in the measuring compartment remained
practically constant. Due to an open measuring compartment and
the water evaporation associated with it, small changes in glucose
concentration occurred during the measurement. As a consequence,
minor ﬂuctuations of the vesicle could be observed at the end of the
measuring period in control experiments and at low nystatin concen-
trations. The measurements were performed at a controlled room
temperature of 23±1 °C and at a constant pH of around 7.5.
2.3. Experimental procedures
The response of the GUVs to nystatin in concentrations between 10
and 1000 μM was studied in two separate sets of experiments. In the
ﬁrst set the methanol was maintained at volume fractions under 10%
in order to minimize its effects (the methanol fraction was increased
by 1% as the nystatin concentration was increased by 100 μM). In the
second set of experiments, in contrast, the combined effects ofmethanol
and nystatin were investigated. For this purpose the methanol volume
fraction was increased by 10% as the nystatin concentration was in-
creased by 100 μM, making it possible to observe their interactions at
methanol volume fractions between 10% and 75%. In addition, the ex-
periments with methanol at low (under 10%) and at high volume frac-
tions (above 10%) without nystatin were performed.
Each timebefore theGUVswere exposed to nystatin and/ormethanol,
control experiments testing the stability of the GUVs were conducted by
the transfer of intact vesicles into the isomolar glucose solution. In an ini-
tial set of experiments,we also thoroughly tested the inﬂuences of themi-
cromanipulation procedure itself on the vesicle's behavior.
2.4. Analysis of the images
The obtained imageswere analyzed on the qualitative and quantita-
tive levels. Qualitatively, an assessment was made of the characteristic
vesicle behavior patterns at different nystatin concentrations. This was
based on a continuous observation of the phase-contrast images within
the ﬁrst 60 min after the vesicle transfer. The images of the vesicle were
kept focused in the equatorial plane. The quantitative analysis of the im-
ages was accomplished as follows. In positive phase-contrast microsco-
py the halo intensity depends on the difference between the refractive
indices of the solutions inside and outside the vesicle, the size of the
vesicle and the properties of the microscope [34]. The intensity was
assessed using the brightness proﬁle along the line across the vesicle
membrane in a radial direction, which was ﬁtted across the halo region
by a Gaussian curve [35]. Since for a constant vesicle size the halo inten-
sity depends solely on the difference between the refractive indices, the
determined halo intensity was used as a measure of the changing
sucrose-glucose ratio inside the vesicle. This was possible since the re-
fractive index of a sucrose solution is higher than that of a glucose solu-
tion of the same concentration. The quantitative results were evaluated
using standard statistical procedures.
3. Results
3.1. Studying the effects of nystatin on the GUVs
The primary goal of our experiments was to study the effects of
nystatin at different concentrations on the GUVs made from POPC.
The results show that the characteristic behavior of the GUVs changed
Fig. 2. Typical relative halo-intensity decrease at different nystatin concentration ranges and
lowmethanol volume fractions: 100 μMnystatin (n=9, 1%methanol) (▼), 200 μMnystatin
(n=7, 2% methanol) (■) and 300 μM nystatin (n=8, 3% methanol) (●). Halo-intensity
values are normalizedwith respect to the initial halo-intensity valueof the individual vesicles.
Data are ﬁtted by three linear ﬁts representing different fading phases, the ﬁrst phase cannot
be shown at high nystatin concentrations (range C) due to its short duration. Vertical bars
represent standard deviations. Average vesicle survival times at≥400 μM nystatin (n≈40;
4%≤methanolb10%) (▲) are added for comparison.
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division, four different, partially overlapping, nystatin concentration
ranges were selected with respect to the vesicle response:
• range A (concentrations up to 150 μM),
• range B (concentrations between 150 and 250 μM),
• range C (concentrations between 250 and 400 μM),
• range D (concentrations above 400 μM).
For range A no signiﬁcant changes in the vesicle behavior were
detected in comparison to the control experiments. The vesicles
remained spherical and stable with no signiﬁcant changes in the
size, phase contrast and halo intensity over a period of 1 hour
(Figs. 1a and 2). Minor ﬂuctuations of the vesicles were observed at
the end of the measuring period.
For the concentration range B, after they were transferred into the
measuring compartment, the vesicles also remained spherical for a
few minutes. Later, various membrane formations evolved gradually,
which were predominantly oriented to the exterior of the vesicles.
Their shapes and sizes were quite diverse, ranging from thin or
thick ﬁlamentous formations, named tethers, which usually trans-
formed into necklace-shaped rows of minute spheres, to disorganized
groups of spheres, which often extended over the majority of the ves-
icle surface (Fig. 1b). However, the most commonly observed forma-
tions were relatively short, thick, external tethers and small spheres,
slowly growing over time. On occasions, we noticed shape transfor-
mations involving changes in the number of spheres, e.g., by merging
with the mother vesicle. The halo intensity of the vesicles was found
to fall by about 30% with respect to the initial intensity (Table 1 and
Fig. 2). The rate of decrease was approximately −7.1×10−5 s−1
during the ﬁrst 10 min. Afterwards, the fading process increased and
the halo intensity dropped to approximately 75% of the initial value at
a rate of−1.3×10−4 s−1. After 35 min the fading process slowed and
then continued at a rate of about−1.2×10−5 s−1 (Table 1).
For the concentration range C the existence of three different se-
quential fading phases was also observed (Fig. 2), however, with a
signiﬁcantly shorter duration of the ﬁrst phase (a few tens of sec-
onds). The vesicles also demonstrated an approximately 10-fold
higher rate of halo intensity decrease compared to the concentrationFig. 1. Characteristic vesicle behavior for nystatin concentration ranges A, B and C (see text
GUVs (nystatin concentration was 100 μM) was identical to the control experiments. b) The
200 μM nystatin solution. Arrows indicate typical structures, gradually evolving from predo
of the observation. Note the absence of these structures on the ﬁrst image. c) The sequence o
nystatin solution. The diameter of all vesicles was around 30 μm.range B (Table 1 and Fig. 2) and an almost complete loss of halo inten-
sity (Table 1 and Fig. 1c, 2). Many transient bursts, not observed in
range B, were detected at regular time intervals, which lasted about
one second (Fig. 3). They could be seen only when they were formed
in proximity to the focal plane of the vesicle and they seemed to al-
ways appear at the same location with respect to the vesicle mem-
brane. Membrane formations were, in contrast to concentration
range B, seldom seen.
The characteristic phenomena for the concentrations above 400 μM
(range D) were vesicle ruptures, denoting a quick disintegration of the
entire vesicle. These ruptures were usually preceded by the formation
of individual or multiple, well-localized bulges in the membrane and
only occasionally by a partial loss of halo intensity. Regarding thefor descriptions): a) The snapshots were taken at 10-min intervals. The behavior of the
snapshots were taken at 4, 28, 32, 37, 45 and 48 min after the vesicle transfer into the
minantly thin tethers at the beginning to spherically shaped necklaces towards the end
f snapshots taken at 1, 3, 7.5, 9.5 and 10.5 min after the vesicle transfer into the 300 μM
Table 1
Comparison of major characteristics of the fading process for nystatin concentration ranges B and C at low methanol volume fractions.
Range Halo intensity decrease Final halo intensity
[% of initial]
First phase Second phase Third phase
Rate [10−4 s−1] Duration [min] Rate [10-4 s -1] Duration [min] Rate [10−4 s−1] Duration [min]
B −0.71 10 −1.3 35 −0.12 15 73
C −5.3 0.6 −13 10 −1.1 10 11
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were observed: fast ruptures (explosions), slow (partial) ruptures and
“stable-opening” ruptures.
Fast ruptures or explosions were the most commonly detected
type of ruptures. The vesicle membrane suddenly opened and the
vesicle, which seemed intact just a fraction of a second ago, simply
disappeared, leaving no visible traces behind (Fig. 4a). The incidence
of explosions was found to increase with increasing nystatin concen-
trations in the solution. Slow or partial ruptures were also frequently
observed. The membrane of the vesicle opened for a fraction of a sec-
ond and a signiﬁcant part of its content leaked out (Fig. 4b). Later, the
membrane resealed. The diameter of the vesicle was found to be con-
siderably reduced (at least by one third). This cycle of membrane
opening and resealing was repeated several times, until the vesicle
disintegrated into lipid debris. Such slow ruptures occurred preferen-
tially at nystatin concentrations of approximately 500 μM. The third
type of rupture was characterized by a stable opening with a distinc-
tive oriﬁce (Fig. 4c). Firstly, a few dark spots or bulges appeared on
the vesicle membrane. They gathered to form the oriﬁce of a stable
opening, through which the sluggish emptying of the vesicle content
began. The diameter of the vesicle gradually decreased, but, on the
other hand, the diameter of the stable opening remained almost con-
stant during the entire emptying process, which lasted for a few sec-
onds. During this process the excessive membrane gathered around
the opening, forming an amorphous relict of the vesicle at the end.
This type of rupture was extremely rare.
In order to get a more complete picture, we should have a more
quantitative look at certain aspects in relation to vesicle ruptures.
The survival time of the vesicles, which denotes the time from the
vesicle transfer into the nystatin solution to the vesicle rupture, de-
creased as the nystatin concentration increased (Fig. 5, dashed line).
The slope of the linear regression line corresponds to a 55 s decrease
of the survival time per 100 μM of nystatin-concentration increase.
The predominant type of vesicle rupture at nystatin concentrations
between 400 μM and 600 μM was observed to be slow ruptures,
while explosions were the most frequently observed type at concen-
trations above 600 μM. The occurrence frequencies of the explosions
were 11%, 29%, 70% and 90% at 400 μM, 500 μM, 600 μM and 700 μM
nystatin concentrations, respectively.
3.2. Control experiments (without nystatin) with low and high methanol
volume fractions
As methanol was used as a solvent for nystatin in the experimental
procedures, we decided to conduct a series of control experimentsFig. 3. Presentation of a typical burst encountered in range C (see text for a detailed expl
(arrow) and a minor fraction of the vesicle content is extruded out of the vesicle (seen as a
(arrow).with methanol (without nystatin) in different volume fractions in the
solution surrounding the GUVs.
The control experiments with no methanol showed that a me-
chanical stress imposed on the vesicles during the micromanipulation
procedure does not affect the behavior of the vesicles to a measurable
extent. During the entire measuring period, neither signiﬁcant shape
changes nor halo-intensity decrease were detected (like in Figs. 1a
and 2). Furthermore, the transfer of vesicles into glucose-methanol
solutions with methanol at volume fractions not exceeding 10% did
not cause any detectable changes.
However, the results of the experiments withmethanol volume frac-
tions higher than 10% differed signiﬁcantly. At a 25% methanol volume
fraction the GUVs started to fade approximately 5 min after the transfer.
Their relative halo intensities decreased to about 10% of the initial value
in the following 20 min at a rate of −7.6×10−4 s−1. Similarly, a de-
crease of the halo intensity was observed for the 50% and 75% methanol
volume fractions, the average halo-intensity decrease rates being seven
and seventeen times higher than the rates for the 25% methanol volume
fraction, respectively (Fig. 6). Several transient membrane bursts were
also observed at all these methanol fractions. In addition, for the 50%
and 75% methanol volume fractions the vesicle diameters gradually de-
creased over time. During the course of this process, lipid aggregations
were seen in the proximity of the membrane bursts.3.3. High methanol volume fractions with signiﬁcant nystatin/methanol
cross-interactions
A methanol volume fraction of 10% was taken as the reference be-
tween the low and highmethanol volume fractions, since it is approx-
imately the volume fraction at which the transition of the membrane
phospholipids from the non-interdigitated to the interdigitated state
occurs [36]. Analogously with experiments at low methanol volume
fractions, the same four characteristic, nystatin-concentration-
dependent vesicle behaviors were observed for high methanol vol-
ume fractions. However, the nystatin concentration intervals of the
four characteristic ranges were found to be shifted by 50–100 μM to-
wards higher values: range A up to 200 μM, range B to concentrations
between 200 μM and 350 μM, range C to concentrations between
350 μM and 500 μM and range D to concentrations above 500 μM. A
comparable shift in the nystatin concentration between the low and
high methanol volume fractions was also found in the measurements
of the vesicle survival times (Fig. 5). Similarly, three different, succes-
sive fading phases were detected in concentration ranges B and C
(Fig. 6). The relative halo-intensity decrease rates in ranges B and Canation). a) Vesicle with a tensed membrane. b) Vesicle membrane opens transiently
light shadow). c) Vesicle with a resealed membrane and d) Vesicle membrane reopens
Fig. 4. Different types of vesicle ruptures (see text for descriptions): a) A typical fast rupture (explosion) of the vesicle. The ﬁrst three snapshots were taken at 0.5, 2 and 2.5 min after the
vesicle transfer into a 600 μM nystatin solution. The fourth snapshot was taken immediately after the third one. b) A typical slow (partial) rupture of the vesicle. The snapshots were
taken about 6 min after the transfer into the 500 μM nystatin solution. Time intervals during the ﬁrst three snapshots were approximately 1.5 s. c) A typical “stable-opening” rupture. The
snapshot on the right was taken 5 min after the transfer of the vesicles into a 400 μM nystatin solution.
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(Tables 1 and 2).
Some behavioral aspects were signiﬁcantly different from those at
low methanol volume fractions. For the concentration range B, exten-
sive lipid networks were the predominant type of membrane forma-
tions (Fig. 7). In addition to the ruptures, another type of behavior
was found for range D, i.e., the appearance of ﬂaccid elongated vesicles.
The vesicles became ﬂaccid and attained an elongated shape in 140 s
±50 s after their transfer; their membranes were ﬂuctuating vividly
and their halo intensity was usually almost completely lost (Fig. 8).Fig. 5. The relationship between the survival time of the vesicles and the nystatin concen-
tration at low methanol volume fractions (4%, 5%, 6% and 7%) (●) and at high methanol
volume fractions (50%, 60%, 75% and 90%) (■) with the lines as a guide to the eye (−−
low methanol volume fractions, ― high methanol volume fractions). Methanol volume
fractions are increasing along each line in accordancewith the increasing nystatin concen-
trations. 7–10 vesicles were observed at each nystatin concentration; vertical bars repre-
sent the 95% safety interval. The occurrence of different types of ruptures is shown in
parentheses (explosions+other types).4. Discussion
Polyene–lipid membrane interactions have been, using different
ﬂuorescent techniques, extensively studied by employing small and
large unilamellar vesicles (SUVs and LUVs) [10,30,31]. Our research
was, in contrast to these studies (which could only be realized at
the level of vesicle populations), focused on the behavior of individual
giant vesicles. We were thus able to obtain a new insight into the
mechanisms induced by nystatin activity at the lipid membrane
level. Firstly, our results are consistent with the previous ﬁndingsFig. 6. Typical relative halo-intensity decrease at different nystatin concentration
ranges and high methanol volume fractions: 100 μM nystatin (n=10, 10% methanol)
(▼), 300 μM nystatin (n=6, 30% methanol) (■), 400 μM nystatin (n=7, 40% metha-
nol) (●). For comparison, open symbols depict the fading dynamics in control experi-
ments with high methanol volume fractions (without nystatin): 25% methanol (n=8)
(○), 50% methanol (n=7) (□) and 75% methanol (n=7) (Δ). Halo-intensity values
are normalized with respect to the initial halo-intensity value of the individual vesicles.
Data are ﬁtted by three linear ﬁts representing different fading phases, the ﬁrst phase
cannot be shown at high nystatin concentrations (range C) due to its short duration.
Vertical bars represent standard deviations. Average vesicle survival times
at≥500 μM nystatin (n≈30; ≥ 50% methanol) (▲) are added for comparison.
Table 2
Comparison of major characteristics of the fading process for nystatin concentration ranges B and C at high methanol volume fractions.
Range Halo intensity decrease Final
halo
intensity
[% of
initial]
First phase Second phase Third phase
Rate [10−4 s−1] Duration [min] Rate [10−4 s−1] Duration [min] Rate [10−4 s−1] Duration [min]
B −1.7 10 −5.3 10 −0.29 30 46
C −1.4 1.3 −7.8 16 −0.32 26 9
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POPC membrane (Table 1 and Figs. 1–5). Moreover, our observations
show that this effect is not negligible and it could have an important
role in membrane-permeability changes, which can lead to cell de-
struction (i.e., antifungal activity, side effects of treatment). Secondly,
as presented in the Results section, three different, characteristic,
concentration-dependent phenomena were revealed: i) vesicle
shape changes and membrane formations at small concentrations
(range B), ii) membrane bursts at intermediate concentrations
(range C) and iii) vesicle ruptures at high concentrations (range D)
of nystatin. It should be noted that the subdivision of the results into
discrete concentration ranges is artiﬁcial and that it was made only
with an intention to stress four distinctly different vesicle behavior
patterns.
4.1. Vesicle shape changes and membrane formations
With respect to the different vesicle shape changes andmembrane
formations, which were observed in the concentration range B, a ten-
dency to initially form thin tethers that was followed by their shape
evolution into necklaces was predominantly observed. This behavior
is consistent with the theories of membrane shape transformations
[37,38] and the theory of pore formation [39–41]. According to the
latter, a two-step process is involved in the formation of a pore: inser-
tion of the pore-forming polypeptides on the lipid membrane in a
horizontal orientation, followed by a repositioning into the mem-
brane in a perpendicular direction. We may assume that the ﬁrst
step, the insertion of the nystatin molecules in the outer membrane
monolayer in the horizontal direction, increases the area of the
outer membrane monolayer compared to the inner one. In contrast,
in the second step, the positioning of the nystatin molecules in the
membrane in a perpendicular direction and their self-aggregation
with pore formation, this increase is diminished. This is due to a sig-
niﬁcantly smaller surface area of the nystatin molecule positioned in
a perpendicular direction relative to the horizontal one [42]. Nystatin
molecules passing into the inner membrane monolayer could also be
a reason for an additional decrease of the relative area difference be-
tween monolayers. Furthermore, the formation of pores (i.e., toroidal
or “wormhole” pores) could enable a “pore-mediated ﬂip-ﬂop” [43],
resulting in an enhanced ﬂow of lipid molecules from the outer to the
inner membrane leaﬂet causing a further diminishment of the previ-
ously increased leaﬂet-area difference. Thus, in accord with theseFig. 7. Extensivemembrane lipid networks (arrow) characteristic for nystatin concentration
range B at high methanol volume fractions.mechanisms, the process of pore formation should be accompanied by
an increase and, subsequently, a decrease of the area difference be-
tween bothmembranemonolayers. These descriptions can only be con-
sidered as qualitative, since the steps of the nystatin concentration
changes in our experiments were too large to get quantiﬁable shape se-
quences. Future studies of GUVs shape changes focused only on this
concentration range might reveal to be the most sensitive indicators
of the subtle nystatin-membrane interactions.
4.2. Membrane bursts and vesicle ruptures
The observed membrane bursts (tension pores) in range C and
vesicle ruptures in range D can be understood as occurring due to
an increase in the membrane tension to a critical level. The repetitive
transient membrane bursts resemble the phenomena encountered
previously (e.g., with equinatoxin II as a pore-forming agent) [35]. In-
creased membrane tension was attributed to the occurrence of os-
motic stress in the vesicles after the transmembrane pores with a
ﬁxed diameter were formed. The transmembrane permeability due
to nystatin pore-forming activity was found to have size-
discriminating properties [44], leading to a higher permeability for
glucose molecules with the radius rg~0.38 nmwith respect to sucrose
molecules with a larger effective hydrodynamic radius (rs~0.52 nm)
[45]. Since, initially, the sucrose solution is inside and the glucose so-
lution is outside the vesicle, the osmolarity in the vesicle is increasing,
which induces an inﬂux of water into the vesicle. It results in an in-
creased volume of the vesicle, associated with an increased mem-
brane tension and a corresponding hydrostatic pressure, which
were conﬁrmed by the model simulations of osmotically driven inﬂux
of water in similar experiments with equinatoxin II and melittin
[35,46]. The membrane burst occurs when the membrane area reaches
its critical value, corresponding to a membrane tension comparable to
the estimated critical tension (rupture strength) of the lipid bilayers,
which is, in dependence on the lipid composition and the rate of tension
change, approximately 1–25 mN/m [47,48]. During the burst, the vesi-
clemembrane opens transiently and aminor fraction of the vesicle con-
tent, including sucrose, is instantaneously and non-selectively extruded
out of the vesicle (Fig. 3). The cycle of membrane opening (bursting)
and resealing is repeated until the solutions inside and outside the ves-
icle are equalized. This mechanism explains a faster fading compared to
the fading in range B (Table 1 and Figs. 1c, 2).
At nystatin concentrations beyond 400 μM(range D), different types
of vesicle ruptures were encountered: slow ruptures, “stable-opening”
ruptures and explosions. These processes could be attributed to a higher
rate of transmembrane exchange of the sugar molecules due to a larger
number of size-selective transmembrane pores and, consequently, a
more intense water inﬂux into the vesicle than in range C. If this ﬂow
exceeds a certain threshold value, the tension pore cannot be resealed
anymore. Thus, the process becomes irreversible and is manifested
as slow ruptures, characterized by a delayed resealing of the mem-
brane after a loss of a greater quantity of the vesicle content
(Fig. 4b), or “stable-opening” ruptures, represented by an opening
with a constant diameter (Fig. 4c). At the highest nystatin concen-
trations even a delayed membrane resealing or a “stable opening”
becomes impossible—explosions take place, which are revealed by
Fig. 8. The behavior of a vesicle at 1.1, 1.9, 2.7 and 3.7 min after its transfer to the 500 μM nystatin solution with a high (50%) methanol volume fraction (see text).
Fig. 9. Time of 50% halo-intensity decrease at different methanol volume fractions as a
measure of nystatin-methanol cross-interactions: at zero (∙∙−∙∙, ▲), 300 μM (−−, ■)
and 400 μM (―, ●) nystatin concentration. The lines are drawn only as a guide to the
eye. Asymptotic behavior of curve at zero nystatin concentration implies no halo intensity
decrease at less than 10% methanol volume fractions. This behavior is indicated by a ver-
tical dotted line at the 10%methanol volume fraction and a curved connecting line (∙∙−∙∙).
642 L. Kristanc et al. / Biochimica et Biophysica Acta 1818 (2012) 636–644a total disintegration of the vesicle (Fig. 4a). In the studies with equi-
natoxin II, it was shown that the acceleration of the fading process with
increasing equinatoxin II concentrations takes place mainly due to an
increase of the surface density of the equinatoxin II transmembrane
pores, while their diameter remains constant [35]. Our results suggest
that this is also true in the case of nystatin and its transmembrane pores.
4.3. Implications of nystatin effects
Our ﬁndings demonstrate that both, the gradual content dissipa-
tion at lower nystatin concentrations as well as the almost instanta-
neous, total content dissipation at higher nystatin concentrations
can be attributed to a single mechanism (cause), i.e., the formation
of selective transmembrane pores by the nystatin molecules. Thus,
the observations of single vesicles allow us to explain a two-stage
model of the nystatin membrane permeabilization [30] by a single
mechanism. The gradual content dissipation which is induced by
the occurrence of the transient tension pores (membrane bursts)
can be correlated to the ﬁrst stage (the “graded” type) of membrane
permeabilization and the fast, total content dissipation, induced by
the vesicle ruptures, can be assigned to the second stage (the “all-
or-none” type).
At this point it should also be made clear that the membrane
bursts, as an alternative and non-selective mechanism of vesicle con-
tent exchange, do not need to be localized in the vicinity of the nysta-
tin pores or other forms of self-aggregated nystatin molecules. We
can assume that the membrane bursts occur at locations with the
smallest bilayer resistance to an increased membrane tension (i.e.,
membrane failures or irregularities) that are not necessarily con-
nected to nystatin molecules. Furthermore, we may even speculate
that the mechanism for the halo-intensity decrease is the same in
range B and in range C. But in contrast to range C, the membrane
bursts should take place over much longer time intervals in range B
and therefore, a ten times slower reduction of the halo intensity in
range B is observed.
The phenomena observed in our measurements occurred at an ap-
proximately ten times higher nystatin concentration than those in the
literature [10,30,31]. This may be attributed to a signiﬁcantly larger
diameter and, consequently, to the different physical characteristics
of the GUVs used in our study in comparison to the LUVs or SUVs
used in other studies. Probably the most important factor to be con-
sidered in this respect is that the volume of the GUVs is larger than
that of the LUVs or SUVs. As a consequence, the processes depending
on the vesicle volume-to-area ratio (i.e., the increase of the mem-
brane tension) take longer periods of time or they need higher pore
densities to be completed in comparable experimental times. The
characteristic time before the onset of the vesicle burst is namely pro-
portional to the ratio between the vesicle radius and the membrane
permeability, which is dependent on the pore density [35]. In addi-
tion, a higher curvature radius of smaller vesicles causes a decreased
packing density of the phospholipid molecules in the head region of
the outer lipid monolayer, which can facilitate the ﬁrst phase of the
incorporation of nystatin into the vesicle membrane [49–51]. The
shift towards higher nystatin concentrations can, moreover, be
explained by the necessity of the larger transmembrane pores toenable the passage of sugar molecules with greater radii compared
to different ions, e.g., potassium, used elsewhere [10,30,31]. It seems
that the above mentioned arguments compensate the fact that there
is less total membrane area in the measuring compartment in our ex-
periments compared to those with LUVs and SUVs. The latter would
namely imply a shift towards lower nystatin concentrations in the ex-
periments with GUVs.
4.4. Effects of methanol and the inﬂuence of nystatin-methanol
cross-interactions
As methanol had to be used in all our experiments as a cosolvent for
the nystatin, control experiments with different methanol volume frac-
tions (without nystatin)were carried out in order to elucidate the effects
of methanol on the vesicle behavior. They revealed the signiﬁcant inﬂu-
ence of methanol alone only at more than 10% volume fractions: the oc-
currence of tension pores accompanied by a decrease of halo intensity
(Figs. 6 and 9) and an observed decrease of vesicle diameters. Therefore,
the cross-interactions between the nystatin and the methanol were as-
sumed to be negligible in the interpretation of the experimental results,
which were obtained withmethanol volume fractions under 10%. This is
in agreement with previous studies [10,30] performed at methanol vol-
ume fractions of less than 6%, where these cross-interactions have not
been considered as a problem. However, for methanol volume fractions
of greater than 10% in the medium surrounding the vesicles, the cross-
interactions between the methanol and the nystatin became evident. In
short, a signiﬁcant shift of the concentration ranges towards higher nys-
tatin concentrations (Figs. 2, 5, 6) shows that the methanol and nystatin
membrane activities aremutually antagonizing (Fig. 9). By recalling also
qualitative features, like the occurrence of extensive membrane net-
works and stable, extremely ﬂaccid and elongated vesicle shapes
detected at high nystatin concentrations (Figs. 7 and 8), we may
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can be attributed to the phase transition of the lipid bilayer from the
state of a non-interdigitated into the state of an interdigitated bilayer
structure, which occurs in the case of POPC vesicles at an about 12%
methanol volume fraction [36,52]. As a consequence of this phase tran-
sition, the membrane becomes progressively thinner as well as more
permeable for electrolytes and, although minimally, to certain larger
non-electrolyte molecules [36,53]. The thinning effect may also hinder
the nystatin from aligning into a transverse intramembrane position
and consequently reduce the nystatin pore-forming ability. The ﬂaccid
and elongated vesicles that were seen only for high methanol volume
fractions (Fig. 8) may even indicate the formation of transmembrane
pores with diameters that are large enough to enable an almost equal
membrane permeability for the glucose and sucrose molecules.
5. Conclusions
The studies of the behavior of GUVs (made out of POPC) using phase-
contrast microscopy and a micropipette manipulation system allow us,
in contrast to many other (spectroscopic) techniques that enable only
the studies on populations of SUVs and LUVs, observations on individual,
cell-sized vesicles.
Vesicle shape changes and membrane formations, nonselective,
transient tension pores and vesicle ruptures were revealed. They rep-
resent three characteristic features, occurring for different nystatin
concentration ranges, which are related to nystatin incorporation
into the phospholipid bilayer. Therefore, our observations conﬁrm
the notion that nystatin is able to form transmembrane pores in phos-
pholipid membranes devoid of sterols.
Vesicle shape changes can be understood if the theories of vesicle
shape transformations and the theory of pore formation are considered.
It can be assumed that the insertion of nystatinmolecules into the outer
membrane monolayer increases its area compared to the inner mono-
layer. On the other hand, the repositioning of nystatin molecules into
the membrane in a perpendicular direction and their self-aggregation
with the pore formation decreases the area difference between lipid
monolayers. This area difference determines the shape of a vesicle.
Both the formation of transient tension pores and vesicle ruptures,
which can be interpreted as graded and ”all-or-none” type permeabi-
lization mechanisms, and the contrast dissipation associated with
them, can be explained as a consequence of the size-selective channel
formation by nystatin molecules in the membrane and the resulting
osmotic phenomena. This allowed us to explain a two-stage model
of nystatin membrane permeabilization, presented elsewhere [30],
by a single mechanism.
The study of cross-interactions between nystatin and methanol,
commonly used as a cosolvent in nystatin solutions, has shown that
they are insigniﬁcant for methanol volume fractions of less than
10%. However, mutually antagonizing effects were observed at higher
volume fractions, leading to signiﬁcantly decreased nystatin pore-
forming efﬁciency. These effects could be attributed to the phase
transition of the lipid bilayer from the state of non-interdigitated
into the state of an interdigitated bilayer structure at higher methanol
volume fractions.
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